BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546 AND Diagnosis
7 results:

  • 1. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
    Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
    Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
    Doğan K; Onder E
    Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The prognostic impact of Claudin 6 in papillary renal cell carcinoma.
    Mikuteit M; Zschäbitz S; Stöhr C; Herrmann E; Polifka I; Agaimy A; Trojan L; Ströbel P; Becker F; Wülfing C; Barth P; Stöckle M; Staehler M; Stief C; Haferkamp A; Hohenfellner M; Macher-Göppinger S; Wullich B; Noldus J; Brenner W; Roos FC; Walter B; Otto W; Burger M; Schrader AJ; Hartmann A; Steffens S; Erlmeier F
    Pathol Res Pract; 2022 Mar; 231():153802. PubMed ID: 35180650
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
    Dudani S; de Velasco G; Wells JC; Gan CL; Donskov F; Porta C; Fraccon A; Pasini F; Lee JL; Hansen A; Bjarnason GA; Beuselinck B; Pal SK; Yuasa T; Kroeger N; Kanesvaran R; Reaume MN; Canil C; Choueiri TK; Heng DYC
    JAMA Netw Open; 2021 Jan; 4(1):e2021869. PubMed ID: 33475752
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
    Naglieri E; Niccoli Asabella A; Nappi AG; Carella C; Ferrari C; Rubini G
    Medicine (Baltimore); 2019 Dec; 98(50):e18093. PubMed ID: 31852068
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnostic and prognostic role of immunohistochemical expression of napsin-A aspartic peptidase in clear cell and papillary renal cell carcinoma: a study including 233 primary and metastatic cases.
    Xu B; Abourbih S; Sircar K; Kassouf W; Aprikian A; Tanguay S; Brimo F
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):206-12. PubMed ID: 23702650
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
    Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
    Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.